High Glucose Alters Proteoglycan Expression and the Glycosaminoglycan Composition in Placentas of Women with Gestational Diabetes Mellitus and in Cultured Trophoblasts

Placenta

Volumn 28, Issue 2-3, 2007, Pages 97-106

  Chen, C P ^a,b   Chang, S C ^c   Vivian Yang, W C ^c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Biglycan; Decorin; Gestational diabetes mellitus; Glycosaminoglycan; Perlecan; Proteoglycan

Indexed keywords

BIGLYCAN; DECORIN; DERMATAN SULFATE; GLUCOSE; GLYCOSAMINOGLYCAN; MESSENGER RNA; PERLECAN; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; PROTEOHEPARAN SULFATE;

ADULT; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TROPHOBLAST; WESTERN BLOTTING;

CELLS, CULTURED; CHONDROITIN; DIABETES, GESTATIONAL; FEMALE; GENE EXPRESSION; GLUCOSE; GLYCOSAMINOGLYCANS; HUMANS; HYPERGLYCEMIA; PLACENTA; PREGNANCY; PROTEOGLYCANS; TROPHOBLASTS;

EID: 33845502506     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2006.02.009     Document Type: Article

References (49)

1. Makhseed M.A., Ahmed M.A., and Musini V.M. Impaired gestational glucose tolerance. Its effect on placental pathology. Saudi Med J 25 (2004) 1241-1244
2. Evers I.M., Nikkels P.G., Sikkema J.M., and Visser G.H. Placental pathology in women with type 1 diabetes and in a control group with normal and large-for-gestational-age infants. Placenta 24 (2003) 819-825
3. Coughlan M.T., Vervaart P.P., Permezel M., Georgiou H.M., and Rice G.E. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 25 (2004) 78-84
4. Jansson T., Ekstrand Y., Bjorn C., Wennergren M., and Powell T.L. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes 51 (2002) 2214-2219
5. Desoye G., and Shafrir E. Placental metabolism and its regulation in health and diabetes. Mol Aspects Med 15 (1994) 505-682
6. Jones C.J., and Fox H. Placental changes in gestational diabetes. An ultrastructural study. Obstet Gynecol 48 (1976) 274-280
7. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67 (1998) 609-652
8. Hocking A.M., Shinomura T., and McQuillan D.J. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 17 (1998) 1-19
9. Yang W-CV, Su T-H, Yang Y-C, Chang S-C, Chen C-Y, Chen C-P. Altered perlecan expression in placental development and gestational diabetes mellitus. Placenta 2005;26:780-88.
10. Lysiak J.J., Hunt J., Pringle G.A., and Lala P.K. Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta 16 (1995) 221-231
11. Li D., Clark C.C., and Myers J.C. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J Biol Chem 275 (2000) 22339-22347
12. Leushner J.R., Tevaarwerk G.J., Clarson C.L., Harding P.G., Chance G.W., and Haust M.D. Analysis of the collagens of diabetic placental villi. Cell Mol Biol 32 (1986) 27-35
13. Rukosuev V.S. Immunofluorescent localization of collagen types I, III, IV, V, fibronectin, laminin, entactin, and heparan sulphate proteoglycan in human immature placenta. Experientia 48 (1992) 285-287
14. Achur R.N., Valiyaveettil M., Alkhalil A., Ockenhouse C.F., and Gowda D.C. Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta. J Biol Chem 275 (2000) 40344-40356
15. Muhlhauser J., Marzioni D., Morroni M., Vuckovic M., Crescimanno C., and Castellucci M. Codistribution of basic fibroblast growth factor and heparan sulfate proteoglycan in the growth zones of the human placenta. Cell Tissue Res 285 (1996) 101-107
16. Iozzo R.V., and San Antonio J.D. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 108 (2001) 349-355
17. Iozzo R.V., Cohen I.R., Grassel S., and Murdoch A.D. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J 302 Pt 3 (1994) 625-639
18. Amenta P.S., Gay S., Vaheri A., and Martinez-Hernandez A. The extracellular matrix is an integrated unit: ultrastructural localization of collagen types I, III, IV, V, VI, fibronectin, and laminin in human term placenta. Coll Relat Res 6 (1986) 125-152
19. San Martin S., and Zorn T.M. The small proteoglycan biglycan is associated with thick collagen fibrils in the mouse decidua. Cell Mol Biol (Noisy-le-grand) 49 (2003) 673-678
20. Wiberg C., Heinegard D., Wenglen C., Timpl R., and Morgelin M. Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J Biol Chem 277 (2002) 49120-49126
21. Bollineni J.S., Alluru I., and Reddi A.S. Heparan sulfate proteoglycan synthesis and its expression are decreased in the retina of diabetic rats. Curr Eye Res 16 (1997) 127-130
22. Vogl-Willis C.A., and Edwards I.J. High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells. Biochim Biophys Acta 1672 (2004) 36-45
23. Menne J., Park J.K., Boehne M., Elger M., Lindschau C., Kirsch T., et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Diabetes 53 (2004) 2101-2109
24. Otsuji T., McLeod D.S., Hansen B., and Lutty G. Immunohistochemical staining and morphometric analysis of the monkey choroidal vasculature. Exp Eye Res 75 (2002) 201-208
25. Witmer A.N., van den Born J., Vrensen G.F., and Schlingemann R.O. Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies. Curr Eye Res 22 (2001) 190-197
26. Ebara T., Conde K., Kako Y., Liu Y., Xu Y., Ramakrishnan R., et al. Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. J Clin Invest 105 (2000) 1807-1818
27. Klein D.J., Cohen R.M., and Rymaszewski Z. Proteoglycan synthesis by bovine myocardial endothelial cells is increased by long-term exposure to high concentrations of glucose. J Cell Physiol 165 (1995) 493-502
28. Conde-Knape K. Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. Diabetes Metab Res Rev 17 (2001) 412-421
29. American College of Obstetricians and Gynecologists. Diabetes and pregnancy technical bulletin no. 20; 1994.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
31. Fink L., Seeger W., Ermert L., Hanze J., Stahl U., Grimminger F., et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 4 (1998) 1329-1333
32. Doolittle M.H., Martin D.C., Davis R.C., Reuben M.A., and Elovson J. A two-cycle immunoprecipitation procedure for reducing nonspecific protein contamination. Anal Biochem 195 (1991) 364-368
33. Mogyorosi A., and Ziyadeh F.N. Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Physiol 275 (1998) F827-F832
34. Wahab N.A., Parker S., Sraer J.D., and Mason R.M. The decorin high glucose response element and mechanism of its activation in human mesangial cells. J Am Soc Nephrol 11 (2000) 1607-1619
35. Templeton D.M., and Fan M.Y. Posttranscriptional effects of glucose on proteoglycan expression in mesangial cells. Metabolism 45 (1996) 1136-1146
36. Urban J.P., Hall A.C., and Gehl K.A. Regulation of matrix synthesis rates by the ionic and osmotic environment of articular chondrocytes. J Cell Physiol 154 (1993) 262-270
37. Chen J., Baer A.E., Paik P.Y., Yan W., and Setton L.A. Matrix protein gene expression in intervertebral disc cells subjected to altered osmolarity. Biochem Biophys Res Commun 293 (2002) 932-938
38. Ishihara H., Warensjo K., Roberts S., and Urban J.P. Proteoglycan synthesis in the intervertebral disk nucleus: the role of extracellular osmolality. Am J Physiol 272 (1997) C1499-C1506
39. Hadad S.J., Michelacci Y.M., and Schor N. Proteoglycans and glycosaminoglycans synthesized in vitro by mesangial cells from normal and diabetic rats. Biochim Biophys Acta 1290 (1996) 18-28
40. Kofoed-Enevoldsen A., and Eriksson U.J. Inhibition of N-acetylheparosan deacetylase in diabetic rats. Diabetes 40 (1991) 1449-1452
41. Yard B., Feng Y., Keller H., Mall C., and van Der Woude F. Influence of high glucose concentrations on the expression of glycosaminoglycans and N-deacetylase/N-sulphotransferase mRNA in cultured skin fibroblasts from diabetic patients with or without nephropathy. Nephrol Dial Transplant 17 (2002) 386-391
42. Marano C.W., Szwergold B.S., Kappler F., Brown T.R., and Matschinsky F.M. Human retinal pigment epithelial cells cultured in hyperglycemic media accumulate increased amounts of glycosaminoglycan precursors. Invest Ophthalmol Vis Sci 33 (1992) 2619-2625
43. Parthasarathy N., and Spiro R.G. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 31 (1982) 738-741
44. Vernier R.L., Steffes M.W., Sisson-Ross S., and Mauer S.M. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int 41 (1992) 1070-1080
45. Whinna H.C., Choi H.U., Rosenberg L.C., and Church F.C. Interaction of heparin cofactor II with biglycan and decorin. J Biol Chem 268 (1993) 3920-3924
46. Delorme M.A., Xu L., Berry L., Mitchell L., and Andrew M. Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta. Thromb Res 90 (1998) 147-153
47. Kolm V., Sauer U., Olgemooller B., and Schleicher E.D. High glucose-induced TGF-beta 1 regulates mesangial production of heparan sulfate proteoglycan. Am J Physiol 270 (1996) F812-F821
48. Border W.A., Noble N.A., Yamamoto T., Harper J.R., Yamaguchi Y., Pierschbacher M.D., et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360 (1992) 361-364
49. Mogyorosi A., and Ziyadeh F.N. What is the role of decorin in diabetic kidney disease?. Nephrol Dial Transplant 14 (1999) 1078-1081